97-OR: Preclinical Characterization of MTX-101, a Novel KIRxCD8 Targeting Bispecific CD8 Treg Modulator
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes"
DOI: 10.2337/db24-97-or
Abstract: Introduction and Objectives: In healthy individuals, activation and expansion of CD8 regulatory T cells (CD8 Treg) leads to selective killing of pathogenic CD4 T cells without broad immunosuppression. In patients with autoimmunity, CD8 Treg appear… read more here.
Keywords: mtx 101; mozart therapeutics; cd8 treg;